Posted 18 January 2021 | By
Welcome to Regulatory Reconnaissance, your day by day regulatory information and intelligence briefing.
In Focus: US
In Focus: US
- AstraZeneca, Daiichi’s breast most cancers drug will get broader US approval (Reuters) (FDA)
- Biden will maintain Dr. Francis Collins as Nationwide Institutes of Well being director: assertion (Reuters)
- Biden warns of challenges forward as he rolls out new vaccine plan (Politico)
- Biden Administration Will Rename ‘Operation Warp Pace,’ Citing Trump ‘Failures’ (NPR) (Politico)
- COVID-19 Provide Deal Lets Vaccine Maker Earmark Doses For Staff And Their Households (NPR)
- Biden to Elevate Science Adviser to His Cupboard (NYTimes) (Science)
- Trump admin enlists non-public agency to evaluate some Covid-19 exams (Politico)
- Well being officers assured Biden will ship on promise of 100 million vaccines in 100 days (Politico)
- The Trump administration bailed out distinguished anti-vaccine teams throughout a pandemic (Washington Put up)
In Focus: Worldwide
- WHO hopes poorer nations can entry Pfizer vaccine ‘very quickly’ (Reuters)
- Chinese language and Russian vaccines in excessive demand as world scrambles for doses (FT)
- Norway says recommendation on use of Pfizer vaccine is unchanged (Reuters)
- Israel sharing COVID-19 knowledge with Pfizer to assist fine-tune vaccine rollout (Reuters)
- UK says vaccine manufacturing is ‘lumpy’ however nonetheless on track for targets (Reuters)
- Sinovac says its COVID-19 vaccine more practical with longer dosing interval (Reuters)
- A Mixture of Satisfaction and Doubts as Modi Launches India’s Covid-19 Vaccine Drive (NYTimes)
- Scientists sort out vaccine security, efficacy and entry at world R&D discussion board (WHO)
- Emergency Committee on COVID-19 advises on variants, vaccines (WHO)
- Vaccine nationalism places world on brink of ‘catastrophic ethical failure’ – WHO chief (Reuters)
ADVERTISEMENT
Coronavirus Pandemic
- Black People Are Getting Vaccinated at Decrease Charges Than White People (KHN)
- US and China conflict at WHO over scientific mission in Wuhan (Reuters)
- EU works to plug massive hole in virus sequencing as COVID variants unfold (Reuters)
- Swiss to get Moderna vaccine in tranches till mid-year: Blick (Reuters)
- Swiss set to approve AstraZeneca COVID vaccine this month: NZZ (Reuters)
- Pakistan approves AstraZeneca COVID-19 vaccine for emergency use (Reuters)
- Pfizer delays Jan. vaccine supply to Bahrain – well being ministry (Reuters)
- Valneva says UK rollout of COVID-19 vaccine may begin in July-Sept – report (Reuters)
- Bayer goals to assist CureVac with COVID-19 vaccine output, says CEO (Reuters)
- Lebanon inks closing deal for two.1 million doses of Pfizer–BioNTech vaccine (Reuters)
- Brazilian approval of Sputnik V vaccine delayed by lacking knowledge (Reuters)
- Brazil clears emergency use of Sinovac, AstraZeneca vaccines, photographs start (Reuters)
- Precedence methods to optimize testing and screening for COVID-19 in Canada: Report (Well being Canada)
Pharma & Biotech
- The bounds of acceptable political affect over the FDA (Nature)
- Accelerating the Adoption of Superior Manufacturing Applied sciences to Strengthen Our Public Well being Infrastructure (FDA)
- Thermo Fisher Shells Out $876M For Viral Vector Maker (Legislation360)
- Well being knowledge agency Target RWE buys NoviSci in Amgen-backed deal (Reuters)
- Janssen Recordsdata Imbruvica for Put up-Transplant GVHD in Japan (PharmaJapan)
- Xalkori baggage FDA inexperienced mild for uncommon paediatric non-Hodgkin lymphomac (PharmaTimes)
- FDA approves Janssen’s AL amyloidosis drug (Pharmafile)
Medtech
- EU Notified Physique Affiliation Takes Steps To Allay EC’s Digital Audit Fears (MedtechInsight)
- ‘Slippery slope territory’: Well being officers suggest waiving regulatory evaluate of medical AI instruments (STAT)
- Session on proposed modifications to the Medical Gadgets Directorate’s Draft Steerage Doc – Listing of Acknowledged Requirements for Medical Gadgets (Well being Canada)
- Neuromod portfolios advance at Medtronic, Boston Scientific, Abbott (MedtechDive)
- NANS 2021: Boston Scientific Advances New Customized Ache Remedy (MedtechInsight)
- Liquid Biopsy Firm Delfi Diagnostics Raised $100M For New Class of Early Most cancers Detection Check (MedtechInsight)
- Pear Therapeutics inks take care of digital tablet firm etectRx (mobihealthnews)
- EU Rule Presents New Medical System Compliance Hurdles (Legislation360)
Authorities, Regulatory & Authorized
- Authorities Report Outlines Prices, Financial savings Of Main Regs (MedtechInsight)
- Supporting a Funds Enhance for FDA for FY 22 (Alliance for a Stronger FDA)
- Maryland Senate overrides governor’s veto of prescription drug affordability board (STAT)
- Compounding Pharmacy Mogul Sentenced for Multimillion-Greenback Well being Care Fraud Scheme (DOJ)
- Ceremony Support Should Face Trial For Inflated Drug price Claims (Legislation360)
- Sanofi Prevails Over Mylan At Fed. Circ. On Jevtana Patent (Legislation360)
- Novo Joins Problem To HHS Pharma Low cost Opinion (Legislation360)
- Fed. Circ. Sticks With Ruling In Bard’s $68M Patent Combat (Legislation360)
Regulatory Recon is our day by day intelligence briefing for the regulatory affairs area, bringing you the highest regulatory, biopharma and medtech information tales from across the globe.
A narrative’s inclusion in Regulatory Recon doesn’t suggest endorsement by Regulatory Focus or RAPS.
